Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0000080255-26-000706

Stakes reported in this filing

Reporting person Shares Of the class
T. Rowe Price Associates, Inc. 5,088,495 4.9%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…